Script section containing code for Liveperson Chat Solution

Hoover's - A D&B Company - We Make It Easier
I'm Ready to Subscribe
Special Offers
DNBi. Leverage D&B's credit assessment tools.

UCB S.A. · Brussels Belgium (Euronext Brussels: UCB)

Allée De La Recherche 60Phone: +32-2-559-99-99
BrusselsFax: +32-2-559-99-00
1070
BelgiumMap Map This Company
  • Company Profiles
  • Competitive Landscapes
  • Industry Reports

Buy Reports

For a Hoover's Free Trial, Call
(866) 444-8642
or
Chat Now

UCB S.A. Rankings

Euronext 100BEL20

Company Description

You see, UCB wants to be a world leader when it comes to treating ailments related to the immune and central nervous systems (CNS). The company manufacturers prescription drugs to treat Crohn's disease, epilepsy, and Parkinson's disease. UCB's top products include Cimzia for Crohn's disease,Vimpat to treat epilepsy, and Neupro for Parkinson's disease. The company also makes allergy blockbuster Zyrtec. UCB has operations in nearly 30 countries, and markets its products through an internal sales force and through strategic relationships with other pharmaceutical companies. Marketing, manufacturing, and development partners include AstraZeneca and Novartis. Financière de Tubize owns a majority stake in UCB.

To read the full description: Subscribe Now
left-headUCB S.A. Reports
right-head

No subscription, no problem.

Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.

Shop Reports
Shop Reports

Financials

Company TypePublic - Euronext Brussels: UCB Headquarters
Fiscal Year-EndDecember
2010 Employees8,898

Executives

38 executives listed for UCB S.A.'s Brussels, Belgium location.

Chairman, Executive Committee, and CEORoch DoliveuxE-mail
ChairmanKarel BooneE-mail
Vice ChairCountess Diego du Monceau de BergendalE-mail

More UCB S.A. Executives

Sponsored Links